Hints and tips:
Related Special Reports
...Timothy Mackey, professor of global health at University of California San Diego, predicted that other pharma companies would probably follow Eli Lilly and Pfizer....
...Rahul Titus, global head of influence at Ogilvy PR, said health influence was the “new frontier” in marketing....
...Other health insurance companies, such as Humana, have also warned of rising medical costs....
...The company also pulled its 2025 target of adjusted earnings of $37 a share. Humana warned investors last week that higher costs were becoming a problem....
...Humana now expects diluted earnings to be $20 a share for the year ended December 31 2023, down from previous guidance of $26.31 a share....
...A combination between Cigna and Humana would help the companies compete with larger rivals such as UnitedHealth Group and Elevance Health, formerly known as Anthem....
...The latest number was unchanged from the government’s forecast in January, dashing hopes of an earnings boost for companies servicing that segment....
...Humana, with significant exposure to Medicare Advantage, was the biggest loser in the S&P 500. Its 13.4 per cent drop on Tuesday represented its third-biggest one-day fall of the past decade....
...Humana warned that costs were rising across the industry as people used more health services. Its shares have fallen more than a fifth since the start of the year....
...Seventy per cent of healthcare companies expect M&A activity in healthcare to increase in 2024 after two relatively quiet years, according to a recent global survey from Jefferies....
...A combined Cigna and Humana would help the companies compete with larger rivals including UnitedHealth Group and Elevance Health....
...US health insurer Cigna has abandoned plans to merge with Humana, a blockbuster transaction that would have created a $140bn insurance company, according to people familiar with the matter....
...Cuban is targeting the 38 per cent of private sector employers who self-insure at least one of their health plans....
...The Arkansas-headquartered company said on Tuesday it would shut all 51 of its health centres across five states, as well as close down its tele-health business after determining there was not a “sustainable...
...J&J was valued at $367bn, as of market close in New York on Thursday....
...Shares of UnitedHealth Group fell 6.3 per cent after rival health insurer Humana said it expects the industry wide trend of high medical costs to become a permanent phenomena, and delivered a grim earnings...
...Share moves to note on the New York Stock Exchange include Macy’s, Cigna, and Tesla: Macy’s surged 20 per cent following reports the department store operator was the subject of a potential $5.8bn buyout...
...But it is a new generation of non-addictive painkillers that analysts say are the most promising drugs in Vertex’s pipeline....
...Shah Capital now owns 6.7 per cent of Novavax, having first bought into the company in the last quarter of 2022....
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...Health insurer Humana and its rival UnitedHealth were also among the largest fallers....
...Some activists argue that the health of workers, consumers and the public at large poses a financial risk that companies have failed to digest....
...The rise and fall of WeightWatchers Sistani describes the new WW as a judgment-free “weight health” company embracing “a full spectrum of solutions”....
...Companies jostling to take advantage of this shift are driving a new wave of mergers and acquisitions in the healthcare industry....
...Eli Lilly’s chief executive David Ricks attributed the drugmaker’s performance to “strong sales of Mounjaro and Zepbound”, and said the company was “rapidly expanding manufacturing capacity to make our incretin...
International Edition